Navigation Links
Kuros Announces Allowance of US Patent for the Local Application of Parathyroid Hormone (PTH) for Bone Healing
Date:7/18/2011

als and bioactive-biomaterial combination products for trauma, wound and spinal indications.

Kuros has two biomaterial technology platforms, one based on fibrin sealants and the other based on its own proprietary synthetic technology that can mimic fibrin in many of its attributes.  These materials can be used alone or in combination with biologically active molecules.

Kuros' combination products are designed to mimic the body's natural healing process. The products consist of fusion proteins of naturally occurring bioactive factors, covalently incorporated into fibrin or synthetic matrices. The incorporation of the biologically active molecules into the injectable matrices aims to maximize their activity by retention at the site of action. Kuros products are designed to combine ease of application with localized delivery.  Kuros has a number of methodologies to achieve the desired retention and release profiles of the biologically active molecules.

Kuros' has a diverse pipeline of product candidates with its most advanced product candidates being in trauma and wound care.

Since its creation, Kuros has raised over $150 million. The company is located in Zurich, Switzerland.

Press Enquiries

Kuros
Didier Cowling, CEO +41(0)44-200-56-62
Alistair Irvine, Director of Business Development +41(0)44-200-56-62

For Swiss Media Enquires:
IRF Communications
Martin Meier-Pfister +41(0)43-244-81-40
Jan Gregor +41(0)43-244-81-54

For International Media Enquires:
Citigate Dewe Rogerson
David Dible, Nina Enegren +44(0)207-638-9571



'/>"/>
SOURCE Kuros Biosurgery AG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The leading ... $13 billion global cardiac rhythm management device market ... found that Medtronic, St. Jude Medical, Boston Scientific ... of this market segment. The healthcare market research ... , uses 2015 as a base year, providing ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)... OF PRUSSIA, Pa. , May 22, 2015  The ... Behring its 2015 Corporate Leadership Award as recognition for ... improving the care of the bleeding disorders community.  The award ... Director, CSL Limited, during the NHF Annual Spring Soiree in ... "The National Hemophilia Foundation is dedicated to finding ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 2National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 3National Hemophilia Foundation Honors CSL Behring with Corporate Leadership Award 4
... YORK, May 13, 2011 Duane Reade Holdings, Inc. today ... new fundraising record for the 26th annual AIDS Walk New ... raises funds for Gay Men,s Health Crisis (GMHC) and 41 ... care, and more to people living with HIV/AIDS, as well ...
... For the second year in a row Royce Colors - ... a supplier recognition from Carestream Health, the world,s leading manufacturer ... which supplies a complete line of Medical and Dental Imaging ... 2010 Supplier of the Year , Carestream,s top supplier ...
Cached Medicine Technology:Duane Reade Celebrates Fourth Year Supporting AIDS Walk New York With Record Donation 2Duane Reade Celebrates Fourth Year Supporting AIDS Walk New York With Record Donation 3Royce Receives Coveted Medical Products Award 2
(Date:5/22/2015)... Pasadena, Calif. (PRWEB) May 22, 2015 ... where technology, communication and capacity are intersecting to ... and across society, the opening speaker at WesternU's ... , California Lieut. Gov. Gavin Newsom, a former ... was the keynote speaker at the graduation ceremony ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... OH (PRWEB) May 22, 2015 River ... that Kyle Johnson, the health system’s Chief Financial Officer ... interests. Johnson has served as the company CFO since ... West will be joining the health system as CFO. ... an interim basis, while the Board of Trustees conducts ...
(Date:5/22/2015)... Following yesterday’s announcement that Ascenta Health ... health brand Nature’s Way, Marc St-Onge has affirmed his ... Skin is an integral part of the agreement with ... to further develop Ascenta Skin into a leading player ... a breakthrough, anti-aging skincare supplement featuring 6 active ingredients ...
(Date:5/22/2015)... Combination therapy, or polytherapy, will ... obstructive pulmonary disorder (COPD) as the dominant companies ... as well as Germany’s Boehringer Ingelheim compete with ... will market payers, clinicians and patients be disposed ... completely new ones? , In spite of recently ...
Breaking Medicine News(10 mins):Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Chronic Obstructive Pulmonary Disorder Therapeutics Market Discussed in In-demand FirstWord Report Published at MarketPublishers.com 2
... N.C., Sept. 21 Whether it is bragged or whispered about, ... recent study by Adam & Eve shows that for most folks, ... (Photo: http://www.newscom.com/cgi-bin/prnh/20090921/LA79100 ) , , (Logo: ... the most trusted name in adult entertainment, recently asked over 1,000 ...
... ... Traumatic Brain Injury , ... September 21, 2009 -- In the current issue of Molecular Medicine, a team of scientists ... progesterone may be beneficial in protecting the brain after traumatic injury. Traumatic brain ...
... children under 10 will need two doses, preliminary U.S. trial ... who are between 10 and 17 years old will apparently ... according to initial results of ongoing trials, U.S. health officials ... two doses of the new H1N1 vaccine, the officials added. ...
... , SACRAMENTO, Calif., Sept. 21 Former California Assembly ... a Purple Ribbon Panel and Task Force starting work today to ... double among Californians by the year 2030. The state has not ... , Brown will be joined by Lloyd Dean, Jonathan ...
... ... face transplant are offering full details about the research, preparation, actual surgery and current ... ... first near-total face transplant, the surgeons involved are offering full details about the research, ...
... , FORT WASHINGTON, Pa., Sept. 21 A ... LACTAID(R) Brand found that 77 percent of Latinas reduce the amount of ... lactose intolerance. Yet, 63 percent of Latinas who have lactose intolerance ... and vitamins A and D. Despite their concerns, only 14 percent ...
Cached Medicine News:Health News:Adam & Eve's 'Great American Sex Survey' Asks 'How Was YOUR First Time?' 2Health News:News from the Latest Issue of Molecular Medicine 2Health News:1 Swine Flu Shot Enough for Older Kids 2Health News:1 Swine Flu Shot Enough for Older Kids 3Health News:Elaine Alquist, Willie Brown and Kim Belshe Convene Purple Ribbon Panel, Task Force on Alzheimer's 2Health News:Details Emerge About Approach, Results of First US Face Transplant 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 2Health News:New Research Finds Latinas with Lactose Intolerance Manage Their Condition by Limiting or Avoiding Dairy 3
Inquire...
... Pectoralis Implants come in three styles. Each ... by far the most popular style. Pectoral ... are packaged and sold individually, not in ... they are each made for a specific ...
... The latest software product in the IQmark ... new, more efficient levels of portability, cost-savings and ... is perfect for use in the office, clinics ... and emergency situations. , ,When used in conjunction ...
... EZ Holter is engineered to set a ... you do is enter the patient demographics, ... ,This three-channel, Windows based system uses the ... accuracy and versatility of the IQmark Holter ...
Medicine Products: